Hematological changes in patients with COVID19 (Review).
Mol Med Rep
; 22(6): 4485-4491, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-979150
ABSTRACT
In December 2019, an emergence of pneumonia was detected in patients infected with a novel coronavirus (CoV) in Wuhan (Hubei, China). The International Committee on Taxonomy of Viruses named the virus severe acute respiratory syndromeCoV2 and the disease CoV disease19 (COVID19). Patients with COVID19 present with symptoms associated with respiratory system dysfunction and hematological changes, including lymphopenia, thrombocytopenia and coagulation disorders. However, to the best of our knowledge, the pathogenesis of COVID19 remains unclear. Therefore, understanding the mechanisms underlying the hematological changes that manifest during COVID19 may aid in the development of treatments and may improve patient prognosis.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Language:
English
Journal:
Mol Med Rep
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS